Stay updated on TAPUR Study: Targeted Drug Clinical Trial
Sign up to get notified when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.

Latest updates to the TAPUR Study: Targeted Drug Clinical Trial page
- ChecktodayChange DetectedAdded multiple new study locations (e.g., Plantation, Sole Mia, Kendall, Griffin Cancer Research Building, Alex's Place, Deerfield Beach, Lennar, and Aventura) and updated corresponding contact details. The total number of locations increased from 166 to 174.SummaryDifference1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAdded new contact details and principal investigator information for TAPUR study sites, including Frank Senecal, MD, and Jen Dalton, MHA, BSN, RN, with multiple locations and phone numbers. Updated the site count to 166 locations and included additional site contacts and emails.SummaryDifference1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This is a metadata update and does not affect study content or user-facing information.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded arms for Dabrafenib plus Trametinib (Group 26) and Fam-trastuzumab deruxtecan-nxki (TDxD) with related mutations and drugs, expanding targeted therapy options; removed several arms (Atezolizumab+PHESGO, Pembrolizumab, Entrectinib, Larotrectinib, ROS1/NTRK groups) and updated the brain metastases exclusion, affecting eligibility and treatment choices.SummaryDifference0.8%

- Check58 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 at the bottom of the page. This is a minor UI/text update with no impact on study information.SummaryDifference0.0%

- Check72 days agoChange DetectedShow glossary feature added. Multiple contact entries and site locations updated, including names, phone numbers, emails, and addresses, and some outdated contacts removed.SummaryDifference0.9%

Stay in the know with updates to TAPUR Study: Targeted Drug Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.